Clinical Trial Update: Polyunsaturates and KCL to Control Mild Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 trial examining the use of polyunsaturated fatty acids in combination with potassium chloride to control mild hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Heart Disease
• Hypertension
• Vascular Disease

Drugs mentioned

• Polyunsaturates (polyunsaturated fatty acids)
• Potassium chloride (Potassium chloride)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Cardiovascular Diseases, Heart Diseases | Phase 2 | Status: COMPLETED